Tag Archives: trial

Venclexta trial deaths force AbbVie, Roche to stop recruiting myeloma patients

AbbVie and Roche are looking to move key oncology drug Venclexta deeper into the blood cancer arena, but their ambitions in multiple myeloma just took a hit. The FDA has halted enrollment in all of Venclexta’s myeloma trials, the companies said Tuesday. The reason? The Venclexta arm of a phase 3 study, dubbed Bellini, turned up a higher… Read More »